Skip to main content

The pot stocks are soaring again after a CBD-based drug took a step closer to commercial launch

Marijuana stocks ripped higher Thursday after the U.S. Drug Enforcement Administration classified a cannabidiol (CBD)-based drug made by GW Pharmaceuticals in its least restrictive category, setting the stage for commercial launch.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.